ArticleOncotarget2017

Silencing PRDM14 expression by an innovative RNAi therapy inhibits stemness, tumorigenicity, and metastasis of breast cancer.

Hiroaki Taniguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.